Notices. Notice
307 words·~1 min read·
/register/2021/02/18/2021-03254·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4120-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2014-N-1027, FDA-2017-N-1064, FDA-2009-N-0380, FDA-2010-N-0588, FDA-2014-N-0487, and FDA-2013-N-1429] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *https://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB control No. Date approval expires Infant Formula Recall Regulations 0910-0188 12/31/2023 State Petitions for Exemption from Preemption 0910-0277 12/31/2023 Product Jurisdiction and Combination Products 0910-0523 12/31/2023 Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile 0910-0614 12/31/2023 Generic Clearance for the Collection of Qualitative Feedback on Food and Drug Administration Service Delivery 0910-0697 12/31/2023 Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the FFDCA and Associated Fees Under Section 744K 0910-0776 12/31/2023 Dated: February 11, 2021. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. [FR Doc. 2021-03254 Filed 2-17-21; 8:45 am]
Connectionstraces to 1
Traces to 1 document